0001562180-21-000283.txt : 20210111 0001562180-21-000283.hdr.sgml : 20210111 20210111162859 ACCESSION NUMBER: 0001562180-21-000283 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210107 FILED AS OF DATE: 20210111 DATE AS OF CHANGE: 20210111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vasista Vittal CENTRAL INDEX KEY: 0001652827 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37553 FILM NUMBER: 21521126 MAIL ADDRESS: STREET 1: C/O REGENXBIO INC. STREET 2: 9600 BLACKWELL ROAD, SUITE 210 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENXBIO Inc. CENTRAL INDEX KEY: 0001590877 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471851754 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9600 BLACKWELL ROAD STREET 2: SUITE 210 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-552-8181 MAIL ADDRESS: STREET 1: 9600 BLACKWELL ROAD STREET 2: SUITE 210 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: REGENXBIO, Inc. DATE OF NAME CHANGE: 20150116 FORMER COMPANY: FORMER CONFORMED NAME: ReGenX Biosciences, LLC DATE OF NAME CHANGE: 20131101 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-01-07 false 0001590877 REGENXBIO Inc. RGNX 0001652827 Vasista Vittal C/O REGENXBIO INC. 9600 BLACKWELL ROAD, SUITE 210 ROCKVILLE MD 20850 false true false false Chief Financial Officer Common Stock 2021-01-07 4 S false 10998.00 50.00 D 134426.00 D Common Stock 2021-01-08 4 S false 2460.00 46.45 D 131966.00 D Common Stock 2021-01-08 4 S false 2208.00 47.49 D 129758.00 D Common Stock 2021-01-08 4 S false 573.00 48.15 D 129185.00 D This transaction was effected pursuant to a Rule 10b5-1 trading plan. This transaction was executed in multiple trades at prices ranging from $50.00 to $50.095. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $45.92 to $46.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $46.92 to $47.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $47.98 to $48.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Patrick J. Christmas as attorney-in-fact 2021-01-11